In vivo Anticancer Potential of Hydroxamic Acid Derivatives

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Cancer remains a significant global health threat despite treatment advances.
• Hydroxamic acid derivatives are investigated as potential anticancer drugs.
• These compounds function as inhibitors of Histone Deacetylases (HDACs).

Purpose of the Study:

• To review recent developments in hydroxamic acid derivatives for cancer treatment.
• To summarize their in vivo anticancer potential.
• To elucidate their mechanisms of action in preclinical models.

Main Methods:

• Literature review of studies published between January 2011 and January 2021.
• Analysis of in vivo data on hydroxamic acid derivatives.
• Examination of signaling pathways involved in their anticancer effects.

Main Results:

• Hydroxamic acid derivatives demonstrate broad anticancer activities.
• They inhibit cancer cell proliferation, induce differentiation, apoptosis, and autophagy.
• These compounds also suppress angiogenesis, invasion, and metastasis.

Conclusions:

• Hydroxamic acid derivatives are promising scaffolds for anticancer drug discovery.
• Their diverse mechanisms of action offer multiple therapeutic strategies.
• Further research into these compounds is warranted for clinical translation.